Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PT-112 in Advanced Solid Tumors and Hepatocellular Carcinoma
CTR20171255Phase 2Active
- Sponsor
- SciClone Pharmaceuticals (Holdings) Limited
- Start
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Imifoplatin in Nonhematologic neoplasms, hepatocellular carcinoma (HCC), sponsored by SciClone Pharmaceuticals (Holdings) Limited. Started Dec 2017; status: active.
02
Drugs
Imifoplatin
03
Conditions
Nonhematologic neoplasmshepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on CTR20171255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20171255.